Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion type Assertion NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_head.
- NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion description "[The host conditioning with low-dose basiliximab may augment the efficacy of AIT for cancer using activated autologous lymphocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_provenance.
- NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion evidence source_evidence_literature NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_provenance.
- NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion SIO_000772 19148493 NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_provenance.
- NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion wasDerivedFrom befree-20140225 NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_provenance.
- NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion wasGeneratedBy ECO_0000203 NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_provenance.